Grand Rounds: Ten Questions About Functional Dyspepsia

Virtual Session:
March 27, 2024, 5:00-6:15 PM EST

On-demand beginning on April 1, 2024

Cost:

MD, PhD, PsyD, BS, MS, MPH – $30
Student, Trainee or Fellow, Non-clinician – No Cost

Only paid registrants – MD, PhD, PsyD, BS, MS, MPH – will receive CME credit

​​​​​​​Earn 1.25 CME credits

A Rome Foundation Continuing Medical Education program

Presentation by Prof. Jan Tack, MD, PhD, and the Leuven Neurogastroenterology and Motility Unit

With guest speakers Bert Broeders, M.D., Cedric Van de Bruaene M.D. and Karen Van Den Houte, M.Sc., Ph.D.

Jan Tack, MD, PhD, RFF
President & Chairman of the Board

Professor of Medicine
Head, Department of Clinical and Experimental Medicine
Head of Clinic, Department of Gastroenterology
University Hospital KU Leuven
Translational Research Center for Gastrointestinal Disorders (TARGID)
Leuven, Belgium

Bert Broeders, M.D.

Cedric Van de Bruaene M.D.

Karen Van Den Houte, M.Sc., Ph.D

Functional dyspepsia is one of the most common and challenging conditions in clinical practice. The last few years have seen major evolutions in the understanding of the disease, its underlying pathophysiology, and the available treatment options. The separation from gastroparesis is an ongoing topic of transatlantic and international debate.

This interactive program will use a case-based approach to reveal some of the current concepts, ongoing controversies, and new information that is likely to be presented at meetings and in the literature later this year.

The program will appeal to clinicians, medical providers, and researchers interested in understanding the complexity of upper gastrointestinal symptoms, their relationship to physiological events such as food intake, and the potential impact of novel pharmacological and dietary therapeutic interventions.

Part 1, Prof. Tack introduces a multi-faceted case of postprandial distress syndrome (PDS) symptoms in addition to nausea and epigastric pain. A personalized view on the traditional diagnostic path and the pathophysiological concept for PDS and epigastric pain syndrome (EPS) will be presented.

Part 2, Dr. Van de Bruaene will address in detail the prevalence and management implications of epigastric pain in PDS and EPS, based on novel data.

Part 3, the case will be further developed, and Dr. Bert Broeders will present novel data on the prevalence and role of nausea in PDS and EPS.

Part 4, presented by Dr. Karen Van den Houte, addresses the role of food as a trigger and of diet as a therapeutic approach in functional dyspepsia. The role of low FODMAP and gluten, 6-food elimination diet, and confocal laser endomicroscopy-based diets will be discussed.

The grand round will be concluded by an interactive discussion based on audience questions.

Objectives for this Grand Rounds include:

1. To understand the complexity of the symptom pattern in functional dyspepsia, in the PDS as well as the EPS subgroup
2. To learn the newest understanding of symptom complexes and the underlying pathophysiology
3. To learn about current and emerging pharmacotherapeutic approaches
4. To learn the newest data on the role of food as a trigger and of diet as a therapeutic approach in functional dyspepsia